Wells Fargo’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1M | Buy |
|
|||||
|
2025
Q1 | $101K | Sell |
|
|||||
|
2024
Q4 | $179K | Sell |
|
|||||
|
2024
Q3 | $4.02M | Sell |
|
|||||
|
2024
Q2 | $6.15M | Buy |
|
|||||
|
2024
Q1 | $8.53M | Buy |
|
|||||
|
2023
Q4 | $7.94M | Sell |
|
|||||
|
2023
Q3 | $5.92M | Buy |
|
|||||
|
2023
Q2 | $8.4M | Sell |
|
|||||
|
2023
Q1 | $6.97M | Buy |
|
|||||
|
2022
Q4 | $876K | Sell |
|
|||||
|
2022
Q3 | $1.34M | Buy |
|
|||||
|
2022
Q2 | $714K | Sell |
|
|||||
|
2022
Q1 | $2.1M | Sell |
|
|||||
|
2021
Q4 | $3.02M | Buy |
|
|||||
|
2021
Q3 | $1.67M | Buy |
|
|||||
|
2021
Q2 | $2.29M | Buy |
|
|||||
|
2021
Q1 | $430K | Sell |
|
|||||
|
2020
Q4 | $2.77M | Buy |
|
|||||
|
2020
Q3 | $799K | Sell |
|
|||||
|
2020
Q2 | $1.33M | Buy |
|
|||||
|
2020
Q1 | $825K | Sell |
|
|||||
|
2019
Q4 | $1.79M | Buy |
|
|||||
|
2019
Q3 | $1.09M | Buy |
|
|||||
|
2019
Q2 | $1.11M | Buy |
|
|||||
|
2019
Q1 | $463K | Sell |
|
|||||
|
2018
Q4 | $337K | Buy |
|
|||||
|
2018
Q3 | $318K | Buy |
|
|||||
|
2018
Q2 | $370K | Buy |
|
|||||
|
2018
Q1 | $136K | Buy |
|
|||||
|
2017
Q4 | $35K | Buy |
|